Home Heart Health A hidden risk in heart failure treatment doctors may ignore

A hidden risk in heart failure treatment doctors may ignore

Credit: Unsplash+

Heart failure is a common and serious health problem, especially in the United States. It affects millions of people and puts a heavy burden on families and the healthcare system.

The condition happens when the heart cannot do its job well enough to supply the body with the blood and oxygen it needs. When this happens, people may feel very tired, short of breath, or notice swelling in their legs and feet because fluid builds up in the body.

Many people think heart failure means the heart is weak and cannot pump properly. This is true for one type of heart failure, where the heart muscle loses strength. However, there is another type that is just as common but less understood.

In this second type, the heart can still pump blood out, but it becomes stiff and cannot relax well. Because it cannot relax, it cannot fill with enough blood between beats. This form is often called “stiff heart” heart failure, or by its medical name, heart failure with preserved ejection fraction (HFpEF).

HFpEF is especially common in older adults and people with conditions like high blood pressure, diabetes, or obesity. Despite how common it is, doctors still do not have many proven treatments for it. This makes it harder to manage compared to the “weak heart” type of heart failure.

One group of medicines often given to heart failure patients is called beta-blockers. These drugs are widely used and have been shown to save lives in people with weak heart failure.

They work by slowing the heart rate, lowering blood pressure, and helping the heart use less energy. Because of these benefits, doctors often prescribe them to many heart patients, including those with HFpEF.

However, new research suggests that beta-blockers may not always be helpful for people with stiff heart failure. In fact, they may sometimes make things worse. A research team from the University of Vermont looked into this issue more closely.

The researchers studied data from a large clinical trial known as the TOPCAT study. This study included many patients who had HFpEF. When the researchers examined the data, they found that about 80 percent of these patients were taking beta-blockers. They then compared outcomes between those who were taking the drugs and those who were not.

The results were surprising and concerning. People with HFpEF who were taking beta-blockers were found to be 74 percent more likely to be hospitalized for heart failure. This means they were more likely to have worsening symptoms that required hospital care.

The reason for this may be linked to how the stiff heart works. In HFpEF, the heart already has trouble relaxing and filling with blood. Beta-blockers can sometimes increase the pressure inside the heart.

When pressure builds up, fluid can collect in the lungs and other parts of the body. This can lead to more breathing problems and swelling, which are key symptoms of heart failure.

This finding is important because it shows that treatments that work well for one type of heart failure may not work for another. It also highlights how much we still need to learn about HFpEF. Doctors have long relied on treatments proven for weak heart failure, but this study suggests that the same approach may not be safe for everyone.

For patients and their families, this research is a reminder that treatment should be carefully tailored to each person’s condition. People with stiff heart failure should talk with their doctors about their medications and ask whether each one is truly helpful for their specific type of heart problem.

The study was led by Dr. Timothy Plante and was published in the medical journal JAMA Network Open. The researchers hope their work will encourage more studies to find better and safer treatments for HFpEF. Right now, there is a clear need for new approaches that focus on the unique features of this condition.

As scientists continue to study heart failure, it is becoming clear that it is not just one disease but a group of different problems that require different solutions. Understanding these differences will be key to improving care and helping patients live longer and healthier lives.

If you care about heart disease, please read studies that herbal supplements could harm your heart rhythm, and how eating eggs can help reduce heart disease risk.

For more health information, please see recent studies that apple juice could benefit your heart health, and results showing yogurt may help lower the death risks in heart disease.

Copyright © 2026 Knowridge Science Report. All rights reserved.